Target intelligence / Profile preview

Immune system allergen recognition pathways

Molecular classification
Pattern recognition receptor (PRR), Toll-like receptor (TLR), C-type lectin receptor (CLR), NOD-like receptor (NLR), RIG-I-like receptor (RLR)
01

Overview

Immune system allergen recognition pathways refer to the collective network of pattern recognition receptors (PRRs), including Toll-like receptors (TLRs) like TLR4, C-type lectin receptors (CLRs) such as dectin-2, DC-SIGN, and mannose receptor, as well as NLRs and RLRs, that detect allergens on dendritic cells, airway epithelial cells, and other innate immune cells. These pathways enable the initial sensing of environmental allergens—proteins from sources like house dust mites (e.g., Der p 2), pollen, or fungi—through motifs mimicking pathogen-associated molecular patterns (PAMPs), such as lipids or carbohydrates, triggering downstream signaling like NF-κB activation and cytokine release. This recognition biases the immune response toward T helper 2 (Th2) polarization, promoting IgE production by B cells, eosinophil recruitment, and mast cell sensitization, which culminate in allergic inflammation. In diseases like allergic asthma and rhinitis, dysregulated pathway activation on mucosal surfaces amplifies type 2 immunity, with epithelial-derived factors like TSLP and IL-33 further sustaining the response. While not a single druggable molecule, these pathways underpin allergenicity, and their modulation is explored indirectly via biologics targeting downstream cytokines (e.g., anti-IL-4/IL-13), though direct inhibitors remain underdeveloped.

Other names
Allergen-specific pattern recognition receptor pathwaysinnate immune pathways in allergyPRR pathways for allergen recognition
02

Biological functions

Recognition of pathogen-associated molecular patterns (PAMPs) and allergens on dendritic cells and epithelial cellsInitiation of Th2-skewed immune responses leading to IgE productionActivation of innate immune cells and modulation of adaptive immunityCytokine and chemokine release (e.g., TSLP, IL-25, IL-33)
03

Disease associations

Allergic diseases (e.g., asthma, atopic dermatitis)Type 2 inflammation and atopy

Beyond the preview

Go deeper on Immune system allergen recognition pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system allergen recognition pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call